analysisWe need to parse the statement. The statement is in Finnish: "Tutkittavana edustavaa prostatakudosta sovituista paikoista. Näytteiden yhteismäärä on riittävä. Nähdään mm. rauhasrakenteita ja jonkin verran aaltoilevaa epiteeliä. Loppupäätelmä on vielä kesken ja valmistuu lähipäivinä. Lääk. Heikki Histopatologi"

We must produce 3 fields: Sampletype, Malignancy, Gleason. Sampletype options: "biopsy", "RP", "TURP", or "NA". Malignancy: "kyllä", "ei", "NA". Gleason: "major+minor=sum" of integers for malignant findings, or "NA" for benign.

We need to infer sample type. The statement mentions "Tutkittavana edustavaa prostatakudosta sovituista paikoista." Likely a prostate tissue sample: "prostatakudosta". No mention of biopsy or RP or TURP. Possibly a sample type unspecified. The phrase "sovituista paikoista" means from agreed sites. Could be a biopsy? It doesn't say "biopsia" explicitly. "Näytteiden yhteismäärä on riittävä." Means number of samples is sufficient. No mention of "biopsy" but could be "biopsy". But sample types are limited to "biopsy", "RP", "TURP" or "NA". If it's an unspecified sample, use NA. The presence of "tutkittavana edustavaa" indicates a sample for study. Not necessarily a biopsy. I'd lean "NA".

Malignancy: The report says "Nähdään mm. rauhasrakenteita ja jonkin verran aaltoilevaa epiteeliä." No malignant features. "Loppupäätelmä on vielä kesken" meaning conclusion incomplete. So no malignancy reported. So "ei". Gleason: Since no malignancy, "NA".

Thus JSON: Sampletype: "NA", Malignancy: "ei", Gleason: "NA".

Return as JSON.assistantfinal{
  "Sampletype": "NA",
  "Malignancy": "ei",
  "Gleason": "NA"
}